REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886FAD9.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $2,760,000 | -9.0% | 500,000 | 0.0% | 1.20% | +0.3% |
| Q2 2015 | $3,033,000 | +13.0% | 500,000 | 0.0% | 1.20% | +13.9% |
| Q1 2015 | $2,684,000 | +10.0% | 500,000 | 0.0% | 1.05% | +10.2% |
| Q4 2014 | $2,439,000 | +15.9% | 500,000 | 0.0% | 0.95% | +15.2% |
| Q3 2014 | $2,105,000 | +25.2% | 500,000 | 0.0% | 0.83% | +28.2% |
| Q2 2014 | $1,681,000 | -5.9% | 500,000 | 0.0% | 0.65% | -8.8% |
| Q1 2014 | $1,786,000 | +8.8% | 500,000 | 0.0% | 0.71% | +6.5% |
| Q4 2013 | $1,641,000 | -11.9% | 500,000 | 0.0% | 0.66% | -14.5% |
| Q3 2013 | $1,863,000 | +38.8% | 500,000 | 0.0% | 0.78% | +32.1% |
| Q2 2013 | $1,342,000 | – | 500,000 | – | 0.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LORD, ABBETT & CO. LLC | 2,525,000 | $16,316,000 | 0.05% |
| Vantage Investment Advisors, LLC | 167 | $91,000 | 0.05% |
| Allianz Asset Management GmbH | 4,835,000 | $31,564,000 | 0.04% |
| GABELLI FUNDS LLC | 500,000 | $3,228,000 | 0.02% |
| SSI INVESTMENT MANAGEMENT LLC | 17,000 | $108,000 | 0.01% |
| WELLS FARGO & COMPANY/MN | 3,143,000 | $20,213,000 | 0.01% |
| BANK OF AMERICA CORP /DE/ | 2,000 | $13,000 | 0.00% |